HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long Huang Selected Research

karyopherin alpha 2

1/2018KPNA2 promotes migration and invasion in epithelial ovarian cancer cells by inducing epithelial-mesenchymal transition via Akt/GSK-3β/Snail activation.
6/2017KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis.
9/2015MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Long Huang Research Topics

Disease

47Neoplasms (Cancer)
01/2022 - 08/2009
12Neoplasm Metastasis (Metastasis)
01/2021 - 09/2009
10Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2009
9Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2018 - 04/2010
8Pancreatic Neoplasms (Pancreatic Cancer)
10/2022 - 12/2016
7Lymphatic Metastasis
12/2018 - 04/2010
6Hepatocellular Carcinoma (Hepatoma)
04/2021 - 01/2012
6Carcinoma (Carcinomatosis)
02/2014 - 09/2009
5Carcinogenesis
09/2017 - 08/2009
4Thrombosis (Thrombus)
01/2022 - 06/2018
4Lung Neoplasms (Lung Cancer)
10/2021 - 07/2010
4AIDS-Related Complex (ARC)
12/2019 - 03/2015
3Adenocarcinoma
04/2022 - 04/2011
3COVID-19
02/2022 - 01/2020
3Portal Hypertension
01/2022 - 03/2015
3Squamous Cell Carcinoma of Head and Neck
01/2022 - 03/2015
3Adenocarcinoma of Lung
10/2021 - 01/2020
3Hemorrhage
01/2021 - 01/2018
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 02/2015
3Ovarian Epithelial Carcinoma
01/2018 - 10/2010
2Bacterial Infections (Bacterial Infection)
11/2022 - 12/2020
2Burns
01/2022 - 01/2021
2Hypersplenism (Anemia, Splenic)
01/2022 - 04/2020
2Small Cell Carcinoma
01/2022 - 01/2012
2Hepatolenticular Degeneration (Wilson's Disease)
01/2022 - 04/2020
2Fibrosis (Cirrhosis)
06/2021 - 04/2016
2Stomach Neoplasms (Stomach Cancer)
11/2020 - 01/2018
2Pancreatic Fistula (Pancreatic Fistulas)
08/2020 - 04/2020
2Pathologic Processes
01/2020 - 01/2017
1Wounds and Injuries (Trauma)
10/2022
1Weight Loss (Weight Reduction)
10/2022
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
02/2022
1Tics (Tic)
01/2022
1Obesity
04/2021
1Inflammation (Inflammations)
04/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Pulmonary Embolism
01/2021

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2020 - 08/2009
13Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2009
9Long Noncoding RNAIBA
10/2022 - 06/2014
5Messenger RNA (mRNA)IBA
01/2020 - 01/2012
3Pharmaceutical PreparationsIBA
10/2022 - 01/2020
3Circular RNAIBA
04/2022 - 05/2021
3Karyopherins (Importin)IBA
01/2022 - 10/2010
3RNA (Ribonucleic Acid)IBA
01/2022 - 04/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 05/2014
3squamous cell carcinoma-related antigenIBA
12/2018 - 04/2010
3karyopherin alpha 2IBA
01/2018 - 09/2015
3CateninsIBA
09/2017 - 03/2015
3Indicators and Reagents (Reagents)IBA
01/2017 - 10/2010
3OligonucleotidesIBA
12/2012 - 04/2011
26-methyladenineIBA
10/2022 - 01/2021
2GemcitabineFDA Link
10/2022 - 04/2022
2DNA (Deoxyribonucleic Acid)IBA
10/2022 - 01/2012
2N-methyladenosineIBA
10/2022 - 01/2021
2GraphiteIBA
01/2022 - 01/2021
2NicotineFDA Link
01/2022 - 01/2021
2PotassiumIBA
01/2022 - 01/2021
2CarbonIBA
01/2022 - 01/2021
2SmokeIBA
01/2022 - 01/2021
2ErbB Receptors (EGF Receptor)IBA
10/2021 - 01/2021
2CyclinsIBA
01/2021 - 01/2018
2Cadherins (E-Cadherin)IBA
01/2021 - 12/2016
2MicellesIBA
12/2020 - 07/2020
2Polysaccharides (Glycans)IBA
12/2020 - 01/2020
2polystyrene polyamine copolymerIBA
12/2020 - 01/2020
2Biological ProductsIBA
09/2017 - 06/2014
2MicroRNAs (MicroRNA)IBA
09/2013 - 01/2012
2Tumor Biomarkers (Tumor Markers)IBA
10/2010 - 08/2009
2Fluorouracil (Carac)FDA LinkGeneric
05/2010 - 11/2009
1Tigecycline (Tygacil)FDA Link
11/2022
1ChitinIBA
10/2022
1HydrogelsIBA
10/2022
1olaparibIBA
04/2022
1VaccinesIBA
02/2022
1biocharIBA
01/2022
1SandIBA
01/2022
1SteelIBA
01/2022
1SolutionsIBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1HMGB1 Protein (HMG1)IBA
01/2022
1Gefitinib (Iressa)FDA Link
10/2021
1CrizotinibIBA
10/2021
1carboxyl radical (COO-)IBA
08/2021
1Blood Glucose (Blood Sugar)IBA
01/2021
1AntigensIBA
01/2021
1AnticoagulantsIBA
01/2021
1Bevacizumab (Avastin)FDA Link
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1osimertinibIBA
01/2021

Therapy/Procedure

13Therapeutics
01/2020 - 10/2009
6Drug Therapy (Chemotherapy)
10/2022 - 05/2010
6Radiotherapy
04/2020 - 07/2010
5Splenectomy
01/2022 - 06/2018
4Hysterectomy
12/2012 - 04/2010
3Hepatectomy
04/2021 - 09/2013
2Length of Stay
01/2021 - 01/2018
2Immunotherapy
01/2021 - 09/2017
2Lymph Node Excision (Lymph Node Dissection)
12/2019 - 04/2010
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
04/2019 - 09/2017